Pages that link to "Q45859478"
Jump to navigation
Jump to search
The following pages link to Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma (Q45859478):
Displaying 14 items.
- Cytokine-secreting tumor cell vaccines (Q34046851) (← links)
- Head and neck cancer: gene therapy approaches. Part II: genes delivered (Q34560682) (← links)
- PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma (Q34649457) (← links)
- Current Advances in Retroviral Gene Therapy (Q35237554) (← links)
- Retroviral vectors for human gene delivery (Q35555170) (← links)
- Vaccines in cancer: GVAX, a GM-CSF gene vaccine (Q36198632) (← links)
- Trial watch: DNA vaccines for cancer therapy (Q36845824) (← links)
- Systemic therapy of disseminated malignant melanoma: an evidence-based overview of the state-of-the-art in daily routine (Q36980823) (← links)
- Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients (Q38890435) (← links)
- Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model (Q40639529) (← links)
- Intratumoral delivery of an interferon gamma retrovirus-producing cells inhibits growth of a murine melanoma by a non-immune mechanism. (Q40775259) (← links)
- Trial Watch: DNA vaccines for cancer therapy (Q42552005) (← links)
- Purification and characterization of cytokine-inducing protein of seed extract from Aeginetia indica L., a parasitic plant (Q74339965) (← links)
- Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant (Q89978477) (← links)